NMRD Nemaura Medical Inc

Price (delayed)

$9.65

Market cap

$221.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$211.63M

Highlights
The quick ratio has contracted by 41% from the previous quarter
Nemaura Medical's net income has decreased by 23% YoY and by 22% from the previous quarter

Key stats

What are the main financial stats of NMRD
Market
Shares outstanding
22.93M
Market cap
$221.28M
Enterprise value
$211.63M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
21.41
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$4.55M
EBITDA
-$4.48M
Free cash flow
-$6.09M
Per share
EPS
-$0.24
Free cash flow per share
-$0.27
Book value per share
$0.45
Revenue per share
$0
TBVPS
$0.73
Balance sheet
Total assets
$17.64M
Total liabilities
$7.31M
Debt
$5.31M
Equity
$10.33M
Working capital
$12.28M
Liquidity
Debt to equity
0.51
Current ratio
3.82
Quick ratio
3.44
Net debt/EBITDA
2.16
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-47.7%
Return on equity
-98.6%
Return on invested capital
-190.8%
Return on capital employed
-34.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NMRD stock price

How has the Nemaura Medical stock price performed over time
Intraday
-8.7%
1 week
-32.8%
1 month
-14.75%
1 year
-29.82%
YTD
155.97%
QTD
26.31%

Financial performance

How have Nemaura Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.55M
Net income
-$5.47M
Gross margin
N/A
Net margin
N/A
Nemaura Medical's net income has decreased by 23% YoY and by 22% from the previous quarter
NMRD's operating income is up by 10% year-on-year

Growth

What is Nemaura Medical's growth rate over time

Valuation

What is Nemaura Medical stock price valuation
P/E
N/A
P/B
21.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 20% from the previous quarter and by 9% YoY
The price to book (P/B) is 87% lower than the 5-year quarterly average of 162.4
NMRD's equity is down by 8% since the previous quarter

Efficiency

How efficient is Nemaura Medical business performance
NMRD's return on equity has surged by 81% year-on-year and by 36% since the previous quarter
The company's return on assets has surged by 63% YoY and by 19% QoQ
The company's return on invested capital rose by 32% QoQ

Dividends

What is NMRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NMRD.

Financial health

How did Nemaura Medical financials performed over time
Nemaura Medical's total assets is 141% higher than its total liabilities
NMRD's current ratio has soared by 151% YoY but it is down by 38% QoQ
The quick ratio has contracted by 41% from the previous quarter
NMRD's debt is 49% less than its equity
NMRD's debt to equity is up by 11% since the previous quarter
NMRD's equity is down by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.